Kura Oncology | BiotechTV

top of page

Dec 9

ASH 2024: Kura Oncology CEO Troy Wilson highlights combination data in 1L AML for the menin inhibitor ziftomenib

He describes the data Kura has presented at ASH and where he believes it puts the company in the competive picture, including why 1L is...

Kura Oncology's CEO gives an update on Q3 earnings day

Nov 2, 2023

Company News

Kura Oncology's CEO gives an update on Q3 earnings day

Troy Wilson describes the science behind Kura's menin inhibitor and farnesyl transferase inhibitor programs.

Follow BiotechTV

Also look for unique social pages for BiotechTV U.

Sponsor Spotlight

Klein Hersh is a precision executive search firm with over 25 years of proven success partnering with clients to deliver the visionary leaders shaping the future of life sciences and healthcare. We believe that the innovation behind a healthier world starts with bringing the best and brightest minds together. Our experienced team of dedicated experts is deeply immersed in every facet of pharma, biotech, and healthcare, and has developed trusted relationships with far-reaching talent networks.

Visit Klein Hersh